Butorphanol tartrate is a synthetic morphinan-type opioid agonist-antagonist analgesic utilized primarily for the management of moderate to severe pain, including migraine headaches. It functions by binding… Read more
Butorphanol tartrate is a synthetic morphinan-type opioid agonist-antagonist analgesic utilized primarily for the management of moderate to severe pain, including migraine headaches. It functions by binding to kappa-opioid receptors while exhibiting partial mu-receptor antagonism, providing analgesia while potentially reducing the risk of respiratory depression associated with pure mu-agonists. The category of butorphanol tartrate products includes essential reference standards, such as the active pharmaceutical ingredient and related impurities like 3,14-dihydroxymorphinan and (-)-3-methoxybutorphanol. Analytical chemists and pharmaceutical laboratories use these compounds for impurity profiling, method validation, and regulatory compliance testing. Furthermore, stable isotope labelled compounds serve as critical internal standards in mass spectrometry-based assays, ensuring high precision in the quantitative analysis and quality control of this analgesic during manufacturing and stability studies.